Alira Health

Alira Health
Contact us
Alira Health
Menu
Home > Education Hub > Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’

Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’

What’s ahead for device companies in 2023? In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations. Deepak Sahu, Partner at Alira Health, has shared his predictions for the year ahead alongside executives from Edwards, Medtronic, Qiagen, and more.

Reports
Category:
MedTech Pharma
Published on:
February 2, 2023
Click here to read all the predictions

Our integrated and multidisciplinary team of over 600 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50 MedTech companies and 75% of the top 50 Pharma companies.

Connect with us to deliver tomorrow’s standard of care in 2023 together

Related news

Events April 1, 2025
The Medtech Forum 2025
Connect with our experts to learn how we can help accelerate patient access to your innovations.
EU HEOR MedTech Pricing
Case Studies March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy Patient Engagement Pharma
Articles March 17, 2025
Heart Failure Medical Devices Market Landscape in 2025
Explore the forces shaping heart failure medical devices, the emerging technologies driving innovation, and the key challenges on the road ahead.
Cardiology Medical Devices MedTech
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
Articles February 17, 2025
Rethinking Rare Disease Development: An Integrated, Patient Access-Driven Approach
Explore how biotech companies can succeed in rare disease by integrating development, commercialization, and patient access.
Patient Centricity Pharma Rare Disease
Events February 13, 2025
Medtech Summit Budapest 2025
Learn how can we help you optimize your regulatory strategy and navigate country-specific regulatory requirements.
EU MedTech
Articles February 11, 2025
From Diagnosis to Long-Term Care: Navigating the Rare Disease Journey
For Rare Disease Day, we spoke with patient engagement expert Luca Trentin on challenges faced by rare disease patients and how pharma can better understand their needs.
Patient Centricity Pharma Rare Disease
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.